Investors Key figures Latest News More news 02.04.2025 Navamedic Welcomes CHMP’s Positive Review of Mysimba’s Cardiovascular Safety 12.02.2025 Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives 10.02.2025 Navamedic ASA: Invitation to 2024 4th quarter presentation Del på: